Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act marked as EEA relevant by the EU and under scrutiny for incorporation into the EEA Agreement by Iceland, Liechtenstein and Norway Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Legal documents
Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028
Durchführungsverordnung (EU) 2023/1784 der Kommission vom 15. September 2023 zur Änderung der Durchführungsverordnung (EU) Nr. 686/2012 hinsichtlich der Übertragung der Überprüfung von Etoxazol, dessen Genehmigung am 31. Januar 2028 ausläuft, an Mitgliedstaaten für die Zwecke des Erneuerungsverfahrens
History
15.09.2023
Adoption date in the EU
08.10.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.